Structural and functional diversity of paraoxonases

Several forms of a paraoxonase enzyme provide different degrees of protection against organophosphate chemicals.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Hyde, E.G. & Carmichael, W.W. Anatoxin-a (S), a naturally occurring organo-phosphate, is an irreversible active site-directed inhibitor of acetyl-cholinesterase (EC 3.1.1. 7). J. Biochem. Toxicol. 6, 195–201 (1991).

  2. 2

    La Du, B.N. Human serum paraoxonase/arylesterase. in Pharmacogenetics of Drug Metabolism (ed. Karlow, W.) 51–91 (Pergamon, New York, 1992).

  3. 3

    Davies, H.G. et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genet. 14, 334–336 (1996).

  4. 4

    Broomfield, C.A. & Ford, K.W. Hydrolysis of nerve agents by plasma enzymes. in Cholinesterases (ed Massoulie, J.). 307 (American Chemical Society, Washington, DC, 1991).

  5. 5

    St Clair, M.H. et al. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557–1559 (1991).

  6. 6

    Adkins, S., Can, K.N., Mody, M. & La Du, B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52, 598–608 (1993).

  7. 7

    Humbert, R. et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet. 3, 73–76 (1993).

  8. 8

    Watson, A.D. et al. Protective effect of high density lipoprotein-associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96, 2882–2891 (1995).

  9. 9

    Sorenson, R.C., Primo-Parmo, S.L., Camper, S.A. & La Du, B.N. The genetic mapping and gene structure of mouse paraoxonase/arylesterase. Genomics 30, 431–438 (1995).

  10. 10

    Primo-Parmo, S.L., Sorenson, R.C., Teiber, J. & The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33, 498–507 (1996).

  11. 11

    Ruiz, J.H. et al. The polymorphism (Gln-Argl92) of the high-density lipoprotein-bound enzyme paraoxonase is an independent cardiovascular risk factor in non-insulin-dependent diabetic patients. Lancet 346, 869–872 (1995).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading